Haemosis 3d vasculography is a revolutionary non-
With a complete vital haemodynamic picture of the heart, lungs, and blood vessels, Haemosis -
Haemosis provides unigue details of minute deiation on flow patterns, invaluable for acxcurate monitoring of cardiac functions. Haemosis 3d vasculography scan is a risk free, accurate and cost effective assessment of cardiovascular functions that aids in clinical evaluation, general, health screening, monitoring of therapy and medical research. It empowers the doctors with more and unigue information of the cardiovascular system, never before possilble non-
Haemosis 3d vasculography uses advanced patented technologies od trans -
Who will benefit from 3D Vasculography?
Symptomatic patients above 30 years of age.
Asymptomatic patients above 35 years of age who want to know their risk status.
High risk patients with a strong family history of:
* Coronary artery disease (CAD)
* High blood pressure
People who are highly stressed or overweight.
People who need optimization of medication.
People who are unable or do not wish to go for invasive diagnostic procedures.
Patients who require a second opinion before going for coronary artery bypass surgery.
People who perform physically demanding jobs such as pilots, police, navy & military personnel.
Corporate companies needing to assess the health status of their key personnel.
Haemosis 3d vasculography is the only technology that can give more than 60 vitalcardoivascular parameters; several of them were never before possible non-
How is 3D Vasculography testing done and how long does it take?
The duration of the test is between 30 to 45 minutes. The patient lies flat on a bed and a system of signal generating and signal receiving electrodes that are attached to cables are strategically placed on the patient's body, together with a highly sensitive Vertical Acceleration Device (VAD). Blood pressure is measured continuously during the test. Trans-
Reliable detection of coronary artery disease and its severity.
Early detection of coronary artery disease in asymptomatic patients.
Establish proneness to sudden cardiac death syndrome (SCDS).
Establish cause of chest pains in undiagnosed cardiac patients.
In critical care medicine-
Establishment of fluid overload during dialysis, plasmapheresis.
Early detection of pulmonary oedema, before the development of clinical symptoms.
Establishment of functional effectiveness of drugs and treatment.
Can be used effectively before, during and after procedures like External Counterpulsation (ECP) or Intra-
An invaluable tool in evaluating the degree of success of Angioplasty, Coronary Artery Stent insertion, Coronary Artery Bypass Grafting (CABG) and Valve Repair surgery.
Approvals & Endorsements
There are currently 150 machines in 20 countries across the world.
The 3D Vasculography device has CE approval which is recognised internationally.